Immunology and Microbiology
Abscess
14%
Adolescence
14%
Antibiotic Sensitivity
23%
Antimicrobial Resistance
34%
Blood Level
14%
Blood Plasma
30%
Chagas Disease
28%
Coma
9%
Empyema
28%
Enterococcus
100%
Enterococcus faecalis
42%
Enterococcus faecium
21%
Epidemiological Data
14%
Forkhead Transcription Factor
28%
Gamma Interferon Inducible Protein 10
28%
Gastrointestinal Tract
5%
Gene Cluster
14%
Hospital Mortality
21%
Human Immunodeficiency Virus
57%
Human Immunodeficiency Virus Infection
35%
Infectious Agent
35%
Lineages
35%
Memory B Cell
28%
Methicillin-Resistant Staphylococcus Aureus
57%
Minimum Inhibitory Concentration
28%
Molecular Epidemiology
28%
Multilocus Sequence Typing
9%
Neglected Disease
28%
Operon
14%
Paranasal Sinus
14%
Pathogenicity Island
14%
Pharmacodynamics
28%
Prevalence
48%
Rare Specie
28%
Regulatory T Cell
28%
Secretion (Process)
28%
Seroprevalence
14%
Staphylococcus Aureus
57%
Transposon
14%
Vancomycin Resistance
57%
Vancomycin-Resistant Enterococcus
57%
Whole Genome Sequencing
7%
Pharmacology, Toxicology and Pharmaceutical Science
Antibiotics
30%
Bloodstream Infection
91%
Carbapenem Derivative
5%
Catheter Infection
5%
Chagas Disease
28%
Ciprofloxacin
5%
Coagulase Negative Staphylococcus
5%
Cohort Study
28%
Daptomycin
60%
Device Infection
28%
Disease
21%
Empyema
28%
Enterococcal Infection
28%
Enterococcus faecalis
7%
Epidemiology
28%
Etravirine
28%
Gamma Interferon Inducible Protein 10
28%
Gram Negative Bacterium
5%
HIV
57%
Hospital Infection
28%
Hospital Mortality
10%
Human Immunodeficiency Virus Infection
28%
Infection
37%
Infection Rate
11%
Infectious Agent
20%
Lactam
9%
Methicillin-Resistant Staphylococcus Aureus
28%
Meticillin
20%
Minimum Inhibitory Concentration
39%
Molecular Epidemiology
28%
Monotherapy
10%
Neglected Disease
28%
Nonnucleoside Reverse Transcriptase Inhibitor
6%
Oritavancin
14%
Osteomyelitis
28%
Patient Acuity
7%
Pharmacodynamics
57%
Pharmacokinetics
7%
Piperacillin Plus Tazobactam
5%
Prevalence
57%
Seroprevalence
14%
Staphylococcal Infection
5%
Staphylococcus Aureus
28%
Third Generation Cephalosporin
5%
Tropical Disease
14%
Vancomycin
60%
Vancomycin-Resistant Enterococcus
42%
Keyphrases
Antibiotic Combination
5%
Antimicrobial Resistance
5%
Clinical Aspects
28%
Clinical Practice
5%
Current Therapeutics
5%
Daptomycin
5%
Empyema Necessitans
28%
Enterococcal Bacteremia
28%
Enterococcal Infections
11%
Enterococcal Isolates
9%
Enterococcus
28%
Epidemiology
5%
Evolution of Antimicrobial Resistance
9%
Future Therapeutics
5%
Gallinarum
28%
Gastrointestinal Tract
5%
Healthcare Workers
5%
Heart Transplant Recipients
9%
Infection Control Measures
5%
Linezolid
5%
Linezolid Resistant Enterococci
28%
Lung Transplantation
9%
Microbiological Failure
14%
Multidrug
11%
Multidrug-resistant
11%
Multiple Determinants
5%
Neglected Diseases
28%
Neglected Tropical Diseases
9%
Nosocomial Infection Rates
7%
Oritavancin
9%
Perinatally Acquired HIV
28%
Perinatally HIV-infected
8%
Perinatally HIV-infected Adolescents
14%
Perinatally HIV-infected children
14%
Rapid Development
5%
Resistance Development
5%
Screening Protocol
9%
Sequence Type 6
9%
Seroprevalence
9%
Solid Organ Transplant Recipients
28%
Therapeutic Decision-making
5%
Tigecycline
5%
Transplant Population
9%
Transplantation
19%
Trypanosoma Cruzi Infection
28%
United States
9%
VanB
28%
VanB Gene
9%
Vector-borne Disease
5%